Subscribe to Updates
Subscribe to our newsletter and never miss our latest news
Subscribe my Newsletter for New Posts & tips Let's stay updated!
Author: IQ TIMES MEDIA
Shanea Leven says she learned two important lessons when building her first company, CodeSee. The first lesson was knowing the difference between what businesses need versus what sounds visionary; the second was that the fundamentals always apply, even with new technologies such as AI. “Security, compliance, reliability, quality, those things don’t just go away for enterprise applications,” she said. After CodeSee was acquired in 2024, Leven decided that she wanted to build a product that would let business owners, even those without technical backgrounds, build AI applications. She teamed up with AI researcher Sean Robinson, and last October, the two launched Empromptu, an…
By Bhanvi Satija and Robin RespautLONDON, Dec 9 (Reuters) – Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo Nordisk to manage the hormonal disorder’s symptoms, according to an exclusive analysis of U.S. patient records and interviews with obesity specialists and gynecologists.U.S. prescriptions for these GLP-1 drugs among women with PCOS have risen more than sevenfold since 2021, a review of 120 million patient records by health data firm Truveta shows. The analysis covered semaglutide and tirzepatide, the main ingredients in Novo’s Wegovy and Lilly’s Zepbound, respectively.”We’re seeing that patients with PCOS…
Worried about how AI is affecting your job? You’re not alone.Everyone from the board to management to employees has concerns about the new technology, said Joe Atkinson, PwC’s global head of AI, in an appearance on CNBC’s Squawk Box Asia on Tuesday.”It’s a complex time in the world of AI implementation,” said Atkinson. The pace of AI change is “overwhelming to everybody” and there’s a “mismatch” between how quickly organizational change can keep up with it, he said.Global companies routinely look to PwC, one of the industry’s leading consulting and accounting firms, for answers to their most consequential business questions.…
BOSTON (AP) — A federal judge has allowed a Tufts University student from Turkey to resume research and teaching while she deals with the consequences of having her visa revoked by the Trump administration, leading to six weeks of detention.The arrest of Rümeysa Öztürk, a PhD student studying children’s relationship to social media, was among the first as the Trump administration began targeting foreign-born students and activists involved in pro-Palestinian advocacy. She had co-authored an op-ed criticizing her university’s response to Israel and the war in Gaza. Caught on video in March outside her Somerville residence, immigration enforcement officers took…
When the Chinese app Rednote launched in 2013, it was mainly used for shopping and cosmetics reviews. Now, it’s one of the hottest hubs for Chinese tech workers in Silicon Valley to talk shop about AI.Rednote is also known as Xiaohongshu, which translates to “Little Red Book.” For Chinese tech workers in the Bay Area working at companies like OpenAI and Meta, Rednote has become a sort of home away from home for shopping and food recommendations. And since the launch of ChatGPT, AI-related content on Rednote has exploded.Technology-related content on the app has more than doubled in the past…
Kalshi’s CEO says his company’s rivalry with Polymarket has parallels to two sets of sporting legends.In an episode of the “20VC” podcast released on Monday, Tarek Mansour explained how prediction market rival Polymarket has encouraged his company to work harder.”What I’m learning over time is that an industry truly becomes an industry when there’s a rivalry, because that rivalry will push you beyond the limits of what you thought you could get to,” Mansour said.He compared the companies to National Football League quarterbacks Tom Brady and Eli Manning.”When Tom Brady kind of reflected on that back in the day, he’s…
Ten years ago, Barbara Cooper’s parents made what they thought was their final move to the Harborside Retirement Community in Port Washington, New York.”They had beautiful brunches every Sunday, intellectual activities that my mom loved. It was just a beautiful place,” Cooper told CBS News.Joyce and Norman Cooper had earned it, saving diligently. To get in, they paid $946,000.”It was a lot of money, but they’d have health care for the rest of their lives in the same building, in the same place and be together,” Barbara Cooper said.The Harborside offered independent living, assisted living, nursing and memory care, all…
By Dietrich KnauthDec 8, Reuters – West Virginia sued United HealthGroup on Monday in federal court, alleging that the company’s pharmacy benefit manager Optum fueled the state’s opioid crisis by oversupplying its communities with addictive painkillers.State Attorney General J.B. McCuskey said West Virginia was already struggling with an addiction crisis when Optum began trying to evade legal safeguards that were meant to limit opioid sales.“Optum saw a business opportunity,” McCuskey said in a statement. “And in its greed, Optum chose to make things worse.”United HealthGroup did not immediately respond to a request for comment.Pharmacy benefit managers handle prescription drug benefits…
2025-12-08T23:05:49.556Z Share Facebook Email X LinkedIn Reddit Bluesky WhatsApp Copy link lighning bolt icon An icon in the shape of a lightning bolt. Impact Link Save Saved Read in app This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? Log in. President Donald Trump announced his approval for Nvidia to sell H200 chips to China. Trump said the US would get a cut of the sales. Nvidia’s stock was up following the announcement. Nvidia just scored a win from President Donald Trump.In a post on Truth Social on Monday, Trump…
Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s risk of developing one of the 13 obesity-related cancers.The findings, published Monday in the Annals of Internal Medicine, may seem counterintuitive, said co-author Dr. Cho-Han Chiang, who conducted the study earlier this year as an internal medicine resident at Mount Auburn Hospital, a Harvard Medical School teaching hospital in Cambridge, Massachusetts.“GLP-1 can make people lose weight, and so, if obesity increases the risk of cancer, then, hypothetically speaking, losing…
